Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection

MeSH terms

• Adult
• Antitubercular Agents / adverse effects
• Antitubercular Agents / therapeutic use*
• Cohort Studies
• Disease Progression
• Drug Therapy, Combination
• Female
• Humans
• Isoniazid / adverse effects
• Isoniazid / therapeutic use*
• Latent Tuberculosis / drug therapy*
• Male
• Patient Compliance
• Portugal
• Pyrazinamide / adverse effects
• Pyrazinamide / therapeutic use*
• Retrospective Studies
• Rifampin / adverse effects
• Rifampin / therapeutic use*